CSIMarket
 


Stryker Corp  (SYK)
Other Ticker:  
 

Cumulative Stryker's Total Debt to Equity for Trailing Twelve Months Period

SYK's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

SYK Total Debt to Equity for Trailing Twelve Months Period

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Equity Growth 10.76 % 12.29 % 11.69 % 16.12 % 13.42 %
Y / Y Total Debt Growth -3.24 % -7.36 % 4.56 % 0.85 % 5.03 %
Total Debt to Equity for Trailing Twelve Months Period 0.77 0.8 0.84 0.85 0.88
Total Ranking # 436 # 1864 # 1920 # 2072 # 2049
Seq. Equity Growth 2.76 % 1.68 % 0.93 % 5.03 % 4.17 %
Seq. Total Debt Growth -0.87 % 0.1 % 2.27 % -4.65 % -5.09 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2023
On the trailing twelve months basis Due to repayements of liabilities of -0.87% Stryker decreased Total Debt to Equity for Trailing Twelve Months Period in the II. Quarter to 0.77, above Stryker's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 17 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Stryker. While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
SYK Charts and Quotes
Total Debt to Equity SYK in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 18
Sector # 40
S&P 500 # 424


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
1.02 0.38 0
(Mar 31 2021)   (Dec. 31. 2009)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Jun 30 2023, within Medical Equipment & Supplies Industry Total Debt to Equity for Trailing Twelve Months Period
Polypid Ltd   1.99 
Eargo Inc   1.92 
Baxter International Inc   1.91 
Pavmed Inc   1.91 
Viveve Medical Inc   1.72 
Uphealth Inc   1.53 
Neuropace Inc   1.46 
Conmed Corporation  1.41 
Minerva Surgical Inc   1.39 
Viewray Inc   1.33 
Novocure Limited  1.30 
3m Company  1.25 
Bioventus Inc   1.19 
Apollo Endosurgery inc   1.18 
Heart Test Laboratories Inc   1.16 
Transmedics Group Inc   1.14 
Artivion Inc   1.12 
Cerus Corporation  1.10 
Dexcom Inc   1.08 
Biolase Inc   1.06 
Nuvasive Inc  1.01 
Assure Holdings Corp   1.00 
Haemonetics Corporation  0.98 
Carlisle Companies Incorporated  0.92 
Cadre Holdings inc   0.91 
Msa Safety Inc  0.89 
Pulse Biosciences Inc   0.83 
Integra Lifesciences Holdings Corp  0.82 
Plus Therapeutics Inc   0.81 
Icu Medical Inc  0.79 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com